4. A stroke of technological genius

Otsuka and NEC are teaming up to create a medicine “bottle” to help increase medication compliance. Apparently the threat of a 2nd stroke isn’t incentive enough for many patients. About half wander off course from their medication regimen after about six months. The new bottle will flash an LED light when a dose is due and will alert a patient’s prescriber of non-compliance. Pletal, Otsuka’s clot-fighting drug that reduces the chance of a second stroke, is optimally effective when taken uninterrupted so there are potentially large health benefits from the technology. This is all well and good until some do-gooder applies the technology to beer bottles that tell your doctor how much you drink. We’re just sayin’ it’s a slippery slope. That’s all.

Now don't be stingy. Share this.Share on FacebookShare on Google+Tweet about this on TwitterShare on LinkedIn

3. Steep price for non-adherence among diabetics

When doctors tell you to take your medicine, eat well, and exercise, you should listen, right? Especially if you have a chronic illness like Type 2 Diabetes. Easier said than done, it seems. The IMS Institute for Healthcare Informatics has released a report showing that under 40% of Type 2 Diabetes patients globally achieve optimal levels of adherence and persistence. 4-15% of costs related to treating Type 2 Diabetes complications are associated with failure to properly follow medication and treatment regimens. In the US, these avoidable complications cost Medicare $4 billion every year. Ouch. Let’s all try listening to our doctors. Let’s lace up our sneakers and go find some Pokémon. Our bodies and wallets will be healthier for it.

Now don't be stingy. Share this.Share on FacebookShare on Google+Tweet about this on TwitterShare on LinkedIn